---
title: "Pfizer teams up with Alloy for antibody discovery"
date: "2025-02-11 17:35:54"
summary: "Pfizer (NYSE:PFE) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform. Under the deal, Alloy will receive an upfront payment from Pfizer (NYSE:PFE) and will be eligible for certain milestone payments, according to a statement from Alloy. Additional financial details were not disclosed...."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Pfizer (NYSE:[PFE](https://seekingalpha.com/symbol/PFE "Pfizer Inc.")) has entered into a multi-year collaboration with Alloy Therapeutics to develop a new antibody discovery platform.

Under the deal, Alloy will receive an upfront payment from Pfizer (NYSE:[PFE](https://seekingalpha.com/symbol/PFE "Pfizer Inc.")) and will be eligible for certain milestone payments, [according to a statement from Alloy.](https://alloytx.com/multi-year-collaboration-with-pfizer-to-develop-new-antibody-discovery-platform/)

Additional financial details were not disclosed.

Alloy said it has collaborated with Pfizer ([PFE](https://seekingalpha.com/symbol/PFE "Pfizer Inc.")) before on various antibody discovery efforts, including utilizing Alloy's ATX-CLC platform.

[seekalpha](https://seekingalpha.com/news/4406154-pfizer-teams-up-with-alloy-for-antibody-discovery)
